Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) EBIT Margin (2020 - 2025)

Celularity has reported EBIT Margin over the past 6 years, most recently at 244.13% for Q3 2025.

  • Quarterly results put EBIT Margin at 244.13% for Q3 2025, down 12013.0% from a year ago — trailing twelve months through Sep 2025 was 209.78% (down 17707.0% YoY), and the annual figure for FY2024 was 70.75%, up 77369.0%.
  • EBIT Margin for Q3 2025 was 244.13% at Celularity, up from 276.57% in the prior quarter.
  • Over the last five years, EBIT Margin for CELU hit a ceiling of 423.47% in Q4 2022 and a floor of 2621.66% in Q3 2023.
  • Median EBIT Margin over the past 5 years was 244.13% (2025), compared with a mean of 624.95%.
  • Biggest five-year swings in EBIT Margin: crashed -248512bps in 2023 and later soared 249766bps in 2024.
  • Celularity's EBIT Margin stood at 307.89% in 2021, then soared by 238bps to 423.47% in 2022, then plummeted by -74bps to 109.93% in 2023, then crashed by -1327bps to 1348.84% in 2024, then soared by 82bps to 244.13% in 2025.
  • The last three reported values for EBIT Margin were 244.13% (Q3 2025), 276.57% (Q2 2025), and 91.77% (Q1 2025) per Business Quant data.